154 related articles for article (PubMed ID: 15139835)
1. Octreotide treatment for sulfonylurea-induced hypoglycaemia.
Crawford BA; Perera C
Med J Aust; 2004 May; 180(10):540-1; author reply 541. PubMed ID: 15139835
[No Abstract] [Full Text] [Related]
2. Long-acting sulfonylureas -- long-acting hypoglycaemia.
Veitch PC; Clifton-Bligh RJ
Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
[No Abstract] [Full Text] [Related]
3. Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.
Barkin JA; Block HM; Mendez PE
Pancreas; 2013 May; 42(4):722-3. PubMed ID: 23591434
[No Abstract] [Full Text] [Related]
4. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
Francis M; Langhan T; Prosser J; Hoffman R
Ann Emerg Med; 2008 Jun; 51(6):795-6; author reply 796-7. PubMed ID: 18489980
[No Abstract] [Full Text] [Related]
5. Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor.
Yamaguchi S; Ikejima M; Furukawa A; Abe M; Nakazaki M; Ishihara H
Diabetes Res Clin Pract; 2015 Aug; 109(2):e8-e10. PubMed ID: 26025695
[TBL] [Abstract][Full Text] [Related]
6. Octreotide: an antidote for sulfonylurea-induced hypoglycemia.
McLaughlin SA; Crandall CS; McKinney PE
Ann Emerg Med; 2000 Aug; 36(2):133-138. PubMed ID: 10918104
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia.
Graudins A; Linden CH; Ferm RP
Am J Emerg Med; 1997 Jan; 15(1):95-6. PubMed ID: 9002583
[No Abstract] [Full Text] [Related]
8. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
Fasano CJ; O'Malley G; Dominici P; Aguilera E; Latta DR
Ann Emerg Med; 2008 Apr; 51(4):400-6. PubMed ID: 17764782
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy of glimepiride].
Kaneko T; Sakamoto N
Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
[No Abstract] [Full Text] [Related]
10. Octreotide for sulfonylurea-induced hypoglycemia following overdose.
Carr R; Zed PJ
Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568
[TBL] [Abstract][Full Text] [Related]
11. Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.
Burge MR; Sood V; Sobhy TA; Rassam AG; Schade DS
Diabetes Obes Metab; 1999 Jul; 1(4):199-206. PubMed ID: 11228754
[No Abstract] [Full Text] [Related]
12. Octreotide for the treatment of sulphonylurea induced hypoglycaemia in type 2 diabetes.
Braatvedt GD
N Z Med J; 1997 May; 110(1044):189-90. PubMed ID: 9201206
[No Abstract] [Full Text] [Related]
13. [Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report].
Nakaya M; Oka R; Miyamoto S
Nihon Ronen Igakkai Zasshi; 2019; 56(3):336-342. PubMed ID: 31366755
[TBL] [Abstract][Full Text] [Related]
14. [Not Available].
Viardot A
Ther Umsch; 2017; 74(8):423-431. PubMed ID: 29461148
[No Abstract] [Full Text] [Related]
15. Octreotide as antidote for sulfonylurea-induced hypoglycemia.
Schier JG; Hirsch ON; Chu J
Ann Emerg Med; 2001 Apr; 37(4):417-8. PubMed ID: 11275841
[No Abstract] [Full Text] [Related]
16. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].
Clerc D; Hugli O; Trueb L; Yersin B
Rev Med Suisse; 2008 Aug; 4(167):1764-7. PubMed ID: 18800755
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylurea-induced hypoglycaemia: use of octreotide.
Hanchard B; Boulouffe C; Vanpee D
Acta Clin Belg; 2009; 64(1):56-8. PubMed ID: 19317242
[TBL] [Abstract][Full Text] [Related]
18. A diabetic woman with worsening heart failure, hunger, and tremor.
Skugor M; Siraj ES
Cleve Clin J Med; 2003 Oct; 70(10):882-8. PubMed ID: 14621233
[No Abstract] [Full Text] [Related]
19. Octreotide therapy for nateglinide-induced hypoglycemia.
Sherk DK; Bryant SM
Ann Emerg Med; 2007 Dec; 50(6):745-6. PubMed ID: 18023765
[No Abstract] [Full Text] [Related]
20. [Hardly any hypoglycemias, constant weight--and still cost effective].
MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
[No Abstract] [Full Text] [Related]
[Next] [New Search]